• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The 2006 Canadian Hypertension Education Program recommendations for the management of hypertension: Part I--Blood pressure measurement, diagnosis and assessment of risk.2006年加拿大高血压教育计划高血压管理建议:第一部分——血压测量、诊断及风险评估
Can J Cardiol. 2006 May 15;22(7):573-81. doi: 10.1016/s0828-282x(06)70279-3.
2
The 2005 Canadian Hypertension Education Program recommendations for the management of hypertension: part 1- blood pressure measurement, diagnosis and assessment of risk.2005年加拿大高血压教育计划关于高血压管理的建议:第1部分——血压测量、诊断及风险评估
Can J Cardiol. 2005 Jun;21(8):645-56.
3
The 2004 Canadian Hypertension Education Program recommendations for the management of hypertension: Part I--Blood pressure measurement, diagnosis and assessment of risk.2004年加拿大高血压教育计划关于高血压管理的建议:第一部分——血压测量、诊断及风险评估
Can J Cardiol. 2004 Jan;20(1):31-40.
4
The 2001 Canadian recommendations for the management of hypertension: Part one--Assessment for diagnosis, cardiovascular risk, causes and lifestyle modification.2001年加拿大高血压管理指南:第一部分——诊断评估、心血管风险、病因及生活方式改变
Can J Cardiol. 2002 Jun;18(6):604-24.
5
The 2000 Canadian recommendations for the management of hypertension: part two--diagnosis and assessment of people with high blood pressure.《2000年加拿大高血压管理指南:第二部分——高血压患者的诊断与评估》
Can J Cardiol. 2001 Dec;17(12):1249-63.
6
The 2007 Canadian Hypertension Education Program recommendations for the management of hypertension: part 1- blood pressure measurement, diagnosis and assessment of risk.2007年加拿大高血压教育计划关于高血压管理的建议:第1部分——血压测量、诊断及风险评估
Can J Cardiol. 2007 May 15;23(7):529-38. doi: 10.1016/s0828-282x(07)70797-3.
7
The 2008 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 1 - blood pressure measurement, diagnosis and assessment of risk.2008年加拿大高血压教育计划高血压管理建议:第1部分——血压测量、诊断及风险评估
Can J Cardiol. 2008 Jun;24(6):455-63. doi: 10.1016/s0828-282x(08)70619-6.
8
The 2009 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 1--blood pressure measurement, diagnosis and assessment of risk.2009年加拿大高血压教育计划高血压管理建议:第1部分——血压测量、诊断与风险评估
Can J Cardiol. 2009 May;25(5):279-86. doi: 10.1016/s0828-282x(09)70491-x.
9
The 2005 Canadian Hypertension Education Program recommendations for the management of hypertension: part II - therapy.2005年加拿大高血压教育计划关于高血压管理的建议:第二部分——治疗
Can J Cardiol. 2005 Jun;21(8):657-72.
10
The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: part I - blood pressure measurement, diagnosis and assessment of risk.2010 加拿大高血压教育计划推荐的高血压管理建议:第一部分 - 血压测量、诊断和风险评估。
Can J Cardiol. 2010 May;26(5):241-8. doi: 10.1016/s0828-282x(10)70378-0.

引用本文的文献

1
Personalized hypertension management based on serial assessment and telemedicine (PHMA): a cluster randomize controlled trial protocol in Anhui, China.基于连续评估和远程医疗的个体化高血压管理(PHMA):中国安徽的一项集群随机对照试验方案。
BMC Cardiovasc Disord. 2021 Mar 12;21(1):135. doi: 10.1186/s12872-021-01943-5.
2
Sonographic assessment of kidneys in patients with hypertension co-existed with diabetes mellitus and ischemic heart disease.高血压合并糖尿病和缺血性心脏病患者肾脏的超声评估
J Family Med Prim Care. 2020 May 31;9(5):2411-2415. doi: 10.4103/jfmpc.jfmpc_50_20. eCollection 2020 May.
3
Adrenal incidentaloma: A puzzle for clinician.肾上腺偶发瘤:临床医生面临的难题。
Indian J Endocrinol Metab. 2013 Oct;17(Suppl 1):S59-63. doi: 10.4103/2230-8210.119507.
4
Associations of epicardial fat with coronary calcification, insulin resistance, inflammation, and fibroblast growth factor-23 in stage 3-5 chronic kidney disease.在 3-5 期慢性肾脏病患者中,心外膜脂肪与冠状动脉钙化、胰岛素抵抗、炎症和成纤维细胞生长因子 23 相关。
BMC Nephrol. 2013 Jan 26;14:26. doi: 10.1186/1471-2369-14-26.
5
Assessment of the Siksika chronic disease nephropathy-prevention clinic.西克西卡慢性病肾病预防诊所评估。
Can Fam Physician. 2013 Jan;59(1):e19-25.
6
Underrepresentation of individuals 80 years of age and older in chronic disease clinical practice guidelines.80 岁及以上人群在慢性病临床实践指南中代表性不足。
Can Fam Physician. 2011 Jul;57(7):e263-9.
7
Estimation of the burden of cardiovascular disease attributable to modifiable risk factors and cost-effectiveness analysis of preventative interventions to reduce this burden in Argentina.评估可改变风险因素导致的心血管疾病负担,以及分析减少阿根廷心血管疾病负担的预防干预措施的成本效益。
BMC Public Health. 2010 Oct 20;10:627. doi: 10.1186/1471-2458-10-627.
8
Effect of adding pharmacists to primary care teams on blood pressure control in patients with type 2 diabetes: a randomized controlled trial.初级保健团队中加入药师对 2 型糖尿病患者血压控制的影响:一项随机对照试验。
Diabetes Care. 2011 Jan;34(1):20-6. doi: 10.2337/dc10-1294. Epub 2010 Oct 7.
9
The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: part I - blood pressure measurement, diagnosis and assessment of risk.2010 加拿大高血压教育计划推荐的高血压管理建议:第一部分 - 血压测量、诊断和风险评估。
Can J Cardiol. 2010 May;26(5):241-8. doi: 10.1016/s0828-282x(10)70378-0.
10
Regulation of the epithelial sodium channel [ENaC] in kidneys of salt-sensitive Dahl rats: insights on alternative splicing.盐敏感型 Dahl 大鼠肾脏中上皮钠通道 [ENaC] 的调节:可变剪接的见解
Int Arch Med. 2009 Sep 29;2(1):28. doi: 10.1186/1755-7682-2-28.

本文引用的文献

1
Applying the 2005 Canadian Hypertension Education Program recommendations: 1. Diagnosis of hypertension.应用2005年加拿大高血压教育计划建议:1. 高血压的诊断。
CMAJ. 2005 Aug 30;173(5):480-3. doi: 10.1503/cmaj.050184.
2
The 2005 Canadian Hypertension Education Program recommendations for the management of hypertension: part II - therapy.2005年加拿大高血压教育计划关于高血压管理的建议:第二部分——治疗
Can J Cardiol. 2005 Jun;21(8):657-72.
3
The 2005 Canadian Hypertension Education Program recommendations for the management of hypertension: part 1- blood pressure measurement, diagnosis and assessment of risk.2005年加拿大高血压教育计划关于高血压管理的建议:第1部分——血压测量、诊断及风险评估
Can J Cardiol. 2005 Jun;21(8):645-56.
4
Masked hypertension assessed by ambulatory blood pressure versus home blood pressure monitoring: is it the same phenomenon?通过动态血压与家庭血压监测评估的隐匿性高血压:是同一现象吗?
Am J Hypertens. 2005 Jun;18(6):772-8. doi: 10.1016/j.amjhyper.2005.01.003.
5
Prognostic significance of left ventricular mass change during treatment of hypertension.高血压治疗期间左心室质量变化的预后意义
JAMA. 2004 Nov 17;292(19):2350-6. doi: 10.1001/jama.292.19.2350.
6
Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study.52个国家中与心肌梗死相关的潜在可改变风险因素的影响(INTERHEART研究):病例对照研究
Lancet. 2004;364(9438):937-52. doi: 10.1016/S0140-6736(04)17018-9.
7
A systematic review of the literature examining the diagnostic efficacy of measurement of fractionated plasma free metanephrines in the biochemical diagnosis of pheochromocytoma.一项关于检测分段血浆游离甲氧基肾上腺素在嗜铬细胞瘤生化诊断中诊断效能的文献系统综述。
BMC Endocr Disord. 2004 Jun 29;4(1):2. doi: 10.1186/1472-6823-4-2.
8
Arm position and blood pressure: an audit.手臂位置与血压:一项审计
Intern Med J. 2004 May;34(5):290-1. doi: 10.1111/j.1444-0903.2004.00592.x.
9
Influence of the presence of doctors-in-training on the blood pressure of patients: a randomised controlled trial in 22 teaching practices.实习医生的存在对患者血压的影响:在22个教学机构进行的一项随机对照试验
J Hum Hypertens. 2004 Nov;18(11):769-73. doi: 10.1038/sj.jhh.1001744.
10
Cardiovascular prognosis of "masked hypertension" detected by blood pressure self-measurement in elderly treated hypertensive patients.老年高血压患者通过自测血压检测出的“隐匿性高血压”的心血管预后
JAMA. 2004 Mar 17;291(11):1342-9. doi: 10.1001/jama.291.11.1342.

2006年加拿大高血压教育计划高血压管理建议:第一部分——血压测量、诊断及风险评估

The 2006 Canadian Hypertension Education Program recommendations for the management of hypertension: Part I--Blood pressure measurement, diagnosis and assessment of risk.

作者信息

Hemmelgarn B R, McAlister Finlay A, Grover Steven, Myers Martin G, McKay Donald W, Bolli Peter, Abbott Carl, Schiffrin Ernesto L, Honos George, Burgess Ellen, Mann Karen, Wilson Thomas, Penner Brian, Tremblay Guy, Milot Alain, Chockalingam Arun, Touyz Rhian M, Tobe Sheldon W

机构信息

Division of Nephrology, University of Calgary, and Foothills Hospital, 1403 29th Street Northwest, Calgary, Alberta, Canada.

出版信息

Can J Cardiol. 2006 May 15;22(7):573-81. doi: 10.1016/s0828-282x(06)70279-3.

DOI:10.1016/s0828-282x(06)70279-3
PMID:16755312
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2560864/
Abstract

OBJECTIVE

To provide updated, evidence-based recommendations for the diagnosis and assessment of adults with high blood pressure.

OPTIONS AND OUTCOMES

For persons in whom a high blood pressure value is recorded, a diagnosis of hypertension is dependent on the appropriate measurement of blood pressure, the level of the blood pressure elevation, the approach used to monitor blood pressure (office, ambulatory or home/self), and the duration of follow-up. In addition, the presence of cardiovascular risk factors and target organ damage should be assessed to determine the urgency, intensity and type of treatment. For persons diagnosed as having hypertension, estimating the overall risk of adverse cardiovascular outcomes requires an assessment for other vascular risk factors and hypertensive target organ damage.

EVIDENCE

MEDLINE searches were conducted from November 2004 to October 2005 to update the 2005 recommendations. Reference lists were scanned, experts were polled, and the personal files of the authors and subgroup members were used to identify other studies. Identified articles were reviewed and appraised using prespecified levels of evidence by content and methodological experts. As per previous years, the authors only included studies that had been published in the peer-reviewed literature and did not include evidence from abstracts, conference presentations or unpublished personal communications.

RECOMMENDATIONS

The present document contains recommendations for blood pressure measurement, diagnosis of hypertension, and assessment of cardiovascular risk for adults with high blood pressure. These include the accurate measurement of blood pressure, criteria for the diagnosis of hypertension and recommendations for follow-up, assessment of overall cardiovascular risk, routine and optional laboratory testing, assessment for renovascular and endocrine causes, home and ambulatory blood pressure monitoring, and the role of echocardiography for those with hypertension. Key features of the 2006 recommendations include continued emphasis on an expedited diagnosis of hypertension, an in-depth review of the role of global risk assessment in hypertension therapy, and the use of home/self blood pressure monitoring for patients with masked hypertension (subjects with hypertension who have a blood pressure that is normal in clinic but elevated on home/self measurement).

VALIDATION

All recommendations were graded according to the strength of the evidence and were voted on by the 45 members of the Canadian Hypertension Education Program Evidence-Based Recommendations Task Force. All recommendations reported herein received at least 95% consensus. These guidelines will continue to be updated annually.

摘要

目的

为成人高血压的诊断和评估提供最新的循证建议。

选项与结果

对于记录到高血压值的人群,高血压的诊断取决于血压的恰当测量、血压升高的水平、监测血压的方法(诊室、动态或家庭/自我测量)以及随访时间。此外,应评估心血管危险因素和靶器官损害的存在情况,以确定治疗的紧迫性、强度和类型。对于被诊断为高血压的患者,估计不良心血管结局的总体风险需要评估其他血管危险因素和高血压靶器官损害。

证据

于2004年11月至2005年10月进行了MEDLINE检索,以更新2005年的建议。对参考文献列表进行了筛选,向专家进行了咨询,并利用作者和亚组成员的个人文件来识别其他研究。由内容和方法学专家根据预先设定的证据水平对识别出的文章进行审查和评估。与前几年一样,作者仅纳入发表在同行评审文献中的研究,不包括摘要、会议报告或未发表的个人交流中的证据。

建议

本文件包含关于成人高血压患者血压测量、高血压诊断以及心血管风险评估的建议。这些建议包括血压的准确测量、高血压诊断标准及随访建议、总体心血管风险评估、常规和可选的实验室检查、肾血管和内分泌病因评估、家庭和动态血压监测以及超声心动图在高血压患者中的作用。2006年建议的关键特点包括继续强调高血压的快速诊断、对全球风险评估在高血压治疗中作用的深入审查,以及对隐匿性高血压患者(诊室血压正常但家庭/自我测量血压升高的高血压患者)使用家庭/自我血压监测。

验证

所有建议均根据证据强度进行分级,并由加拿大高血压教育计划循证建议工作组的45名成员投票表决。本文报告的所有建议均获得至少95%的共识。这些指南将继续每年更新。